4.6 Editorial Material

Running the Light: Nucleotide Metabolism Drives Bypass of Senescence in Cancer

Journal

TRENDS IN BIOCHEMICAL SCIENCES
Volume 44, Issue 12, Pages 991-993

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibs.2019.10.007

Keywords

-

Funding

  1. University of Michigan Center for Gastrointestinal Research Pilot Feasibility Program [P30DK034933]
  2. National Cancer Institute (NCI) National Research Service Award (NRSA) Award [F32CA228328]
  3. Taubman Institute
  4. Forbes Institute for Cancer Discovery
  5. Clinician Scientist Development Award from the American Cancer Society (ACS)
  6. Career Development award from the NCI [K08CA234416]
  7. 2017 American Association for Cancer Research (AACR) NextGen Grant for Transformative Cancer Research [17-20-01-LYSS]
  8. ACS Research Scholar Grant [RSG-18-18601]
  9. Cancer Center Core Grant [P30CA46592]

Ask authors/readers for more resources

Senescence is engaged in response to oncogenes to suppress proliferation. Cancers rewire metabolism to facilitate proliferation; however, it is not well appreciated how this enables senescence bypass. Recent work by Buj et al. demonstrates that loss of the tumor suppressor p16 engages a mTORC1-dependent increase in nucleotide pools to override senescence.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available